We are live on
!
Find out more
Asset Management One Portfolio holdings
AUM
$39B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.12%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.82%
5 Year Est. Return
+143.22%
10 Year Est. Return
+503.7%
AUM
$7.24B
AUM Growth
+$542M
(+8.1%)
Cap. Flow
+$601M
Cap. Flow
% of AUM
8.29%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
1,322
New
166
Increased
421
Reduced
404
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$23M |
| 2 |
Gilead Sciences
GILD
|
+$18.6M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$17.3M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$16.3M |
| 5 |
Biogen
BIIB
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$20M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$13.1M |
| 3 |
RTN
Raytheon Company
RTN
|
+$10.6M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$10.5M |
| 5 |
Regency Centers
REG
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 30.07% |
| 2 | Healthcare | 13.94% |
| 3 | Technology | 8.1% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
RTX Corp
RTX
$289B
| $11.3M | 0.16% |
170,539
-14,867
| -8% | -$1.02M |
|
152
McKesson
MCK
$101B
| $11.3M | 0.16% |
57,600
+12,338
| +27% | +$2.37M |
|
153
DuPont de Nemours
DD
$18.7B
| $11.2M | 0.15% |
82,962
-2,503
| -3% | -$334K |
|
154
Phillips 66
PSX
$84.4B
| $10.9M | 0.15% |
133,733
+14,679
| +12% | +$1.22M |
|
|
CTRX
155
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $10.9M | 0.15% |
255,849
+212,814
| +495% | +$9.67M |
|
156
Weyerhaeuser
WY
$16.9B
| $10.9M | 0.15% |
337,967
-171,143
| -34% | -$5.61M |
|
157
EOG Resources
EOG
$77.5B
| $10.7M | 0.15% |
105,374
-36,497
| -26% | -$3.97M |
|
|
STJ
158
DELISTED
St Jude Medical
STJ
| $10.7M | 0.15% |
175,114
+122,419
| +232% | +$8M |
|
|
WRI
159
DELISTED
Weingarten Realty Investors
WRI
| $10.7M | 0.15% |
336,096
-19,359
| -5% | -$644K |
|
160
Halliburton
HAL
$26.4B
| $10.6M | 0.15% |
162,716
-5,045
| -3% | -$346K |
|
161
Douglas Emmett
DEI
$2.02B
| $10.6M | 0.15% |
409,704
-1,585
| -0.4% | -$44.6K |
|
162
Southern Company
SO
$106B
| $10.6M | 0.15% |
242,635
+73,614
| +44% | +$3.23M |
|
|
SHPG
163
DELISTED
Shire pic
SHPG
| $10.5M | 0.15% |
+40,425
| New | +$10M |
|
|
NPSP
164
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $10.5M | 0.15% |
389,656
+291,227
| +296% | +$8.36M |
|
165
McDonald's
MCD
$191B
| $10.5M | 0.15% |
109,449
-10,925
| -9% | -$1.04M |
|
166
Terreno Realty
TRNO
$7.65B
| $10.5M | 0.14% |
552,270
+46,125
| +9% | +$894K |
|
|
PRXL
167
DELISTED
Parexel International Corp
PRXL
| $10.4M | 0.14% |
164,750
+116,490
| +241% | +$6.64M |
|
168
Thermo Fisher Scientific
TMO
$214B
| $10.4M | 0.14% |
85,153
-8,165
| -9% | -$993K |
|
|
WPG
169
DELISTED
Washington Prime Group Inc.
WPG
| $10.4M | 0.14% |
66,658
+2,196
| +3% | +$372K |
|
|
RPAI
170
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $10.4M | 0.14% |
707,530
+118,047
| +20% | +$1.82M |
|
171
Perrigo
PRGO
$1.43B
| $10.3M | 0.14% |
68,521
+46,148
| +206% | +$6.88M |
|
172
Cousins Properties
CUZ
$5.25B
| $10.2M | 0.14% |
299,754
+10,632
| +4% | +$378K |
|
|
DLR.PRE
173
DELISTED
DIGITAL REALTY TRUST, INC. REDEEMABLE PFD SER E
DLR.PRE
| $10.2M | 0.14% |
400,000
| – | – |
|
|
PCP
174
DELISTED
PRECISION CASTPARTS CORP
PCP
| $10.1M | 0.14% |
42,481
+13,187
| +45% | +$3.2M |
|
175
Equity Lifestyle Properties
ELS
$12.7B
| $10.1M | 0.14% |
472,526
-407,786
| -46% | -$9.04M |
|
Similar funds
Asset Management One's Q3 2014 Portfolio in Review
As of Q3 2014, Asset Management One held 1,322 positions worth $7.24B, up 8.1% from $6.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Asset Management One deployed $601M of net new capital in Q3 2014, opening 166 new positions and adding to 421 existing holdings. Its largest new stake was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
By sector, the portfolio is most concentrated in Real Estate at 30% of assets, down from 34% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was American Tower, an estimated $20M trimmed.
- Asset Management One's largest Q3 2014 buy was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
- Asset Management One added most to AbbVie in Q3 2014, an estimated $23M increase.
- Asset Management One's biggest Q3 2014 reduction was American Tower, cutting an estimated $20M.
- Asset Management One fully exited Orbital ATK, Inc. in Q3 2014, selling an estimated $9.2M.
- Asset Management One's ten largest holdings make up 14% of its $7.24B portfolio in Q3 2014.
- Asset Management One opened 166 new positions and closed 77 in Q3 2014.
- Asset Management One's portfolio value rose 8.1% quarter-over-quarter to $7.24B.
Based on Asset Management One's 13F filing for Q3 2014, filed 5 Nov 2014.